FDA Drops Age Limit for Neffy - Top_Thought_Leaders - MDSpire

FDA Drops Age Limit for Neffy

Needle-free epinephrine expands access for younger children meeting weight criteria

By
Kathryn Wighton
March 27, 2026
2 min

Conexiant

Share

Top Thought Leaders in Pathology

Brief introduction explaining scope and methodology.

Original Source(s)

Conexiant

FDA Drops Age Limit for Neffy

by Kathryn Wighton
March 27, 2026

Related Content

Conexiant

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

by Kathryn Wighton
May 20, 2026
5 min

Frontiers In Endocrinology

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Frontiers In Pediatrics

Long-term epidemiological patterns of pediatric infectious diseases in an urban district of Shanghai, 2015–2023